Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Cell Biology
• Biochemistry

Background:

• Preeclampsia pathophysiology involves placental oxidative stress, but antioxidant therapies have failed.
• Mitochondrial dysfunction is a potential source of oxidative stress in preeclampsia.

Purpose of the Study:

• To investigate the role of mitochondrial reactive oxygen species in endothelial dysfunction in preeclampsia.
• To evaluate the therapeutic potential of mitochondrial-targeted antioxidants.

Main Methods:

• Human umbilical vein endothelial cells were exposed to plasma from preeclampsia or uncomplicated pregnancies.
• Mitochondrial function, superoxide generation, inflammatory marker expression (TNF-α, TLR-9, ICAM-1), and cell death were assessed.
• Cells were pre-treated with MitoTempo, a mitochondrial-targeted antioxidant.

Main Results:

• Preeclampsia plasma significantly decreased mitochondrial function and increased mitochondrial superoxide generation.
• Increased expression of inflammatory markers was observed in cells treated with preeclampsia plasma.
• MitoTempo protected cells from hydrogen peroxide-induced death, reduced mitochondrial superoxide, normalized metabolism, and altered the inflammatory profile.

Conclusions:

• Mitochondrial redox signaling plays a role in preeclampsia pathogenesis.
• Mitochondrial-targeted antioxidants, such as MitoTempo, are promising therapeutic candidates for preeclampsia.